What is NDC 66794-233?

66794-233 is the product NDC for Dexmedetomidine, Dexmedetomidine hydrochloride 200 ug/2mL injection, solution, listed with the FDA by Piramal Critical Care Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

Piramal Critical Care Inc, NDC labeler code 66794. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dexmedetomidine?

12 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dexmedetomidine NDC 66794-233 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)66794-233Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66794-0233Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66794-233-42	6679402334266794023342	25 VIAL, GLASS in 1 CARTON (66794-233-42) / 2 mL in 1 VIAL, GLASS (66794-233-02)Marketed from May 1, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexmedetomidine
Generic name (nonproprietary): dexmedetomidine
Active ingredients: Dexmedetomidine hydrochloride — 200 ug/2mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Piramal Critical Care IncNDC labeler code 66794
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202126
Marketing start: May 1, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha2-Agonists (Mechanism)General Anesthesia (Physiologic effect)
Identifiers: Product ID 66794-233_552143bf-29d0-9fdc-e063-6394a90a7b7cSPL ID 552143bf-29d0-9fdc-e063-6394a90a7b7cSPL set ID c116d83f-35da-19ca-e053-2a95a90a017dRxCUI 309710UNII 1018WH7F9I
Pharmacologic class: Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N466794023342 followed by a unit qualifier and the quantity

Package 66794-0233-42. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 26, 2026.

Indications (excerpt from the label)

Dexmedetomidine injection is a alpha 2 -adrenergic receptor agonist indicated for: Sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. Administer dexmedetomidine injection by continuous infusion not to exceed 24 hours. ( 1.1 ) Sedation of non-intubated adult patients prior to and/or during surgical and other procedures. ( 1.2 ) Sedation of non-intubated pediatric patients aged 1 month to less than 18 years prior to and during non-invasive procedures. ( 1.2 ) 1.1 Intensive Care Unit Sedation Dexmedetomidine injection is indicated for sedation of initially intubated and mechanically ventilated adult patients during treatment…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 66794-233

What is NDC 66794-233?: 66794-233 is the product NDC for Dexmedetomidine, Dexmedetomidine hydrochloride 200 ug/2mL injection, solution, listed with the FDA by Piramal Critical Care Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dexmedetomidine.
What is the active ingredient?: Dexmedetomidine hydrochloride.
Who is the labeler?: Piramal Critical Care Inc, NDC labeler code 66794. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dexmedetomidine?: 12 other product NDCs are listed under this name. See all Dexmedetomidine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dexmedetomidine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dexmedetomidine	Dexmedetomidine hydrochloride 100 ug/mL	Injection, Solution, ConcentrateIntravenous	Avenacy Inc.	83634-600	83634-0600-02
Dexmedetomidine	Dexmedetomidine hydrochloride 100 ug/mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-527	68083-0527-25
Dexmedetomidine	Dexmedetomidine hydrochloride 200 ug/2mL	Injection, SolutionIntravenous	Piramal Critical Care Inc	66794-230	66794-0230-42
Dexmedetomidine	Dexmedetomidine hydrochloride 200 ug/2mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7323	71872-7323-01
Dexmedetomidine	Dexmedetomidine hydrochloride 200 ug/2mL	Injection, SolutionIntravenous	ProPharma Distribution	84549-230	84549-0230-42
Dexmedetomidine	Dexmedetomidine hydrochloride 100 ug/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-505	71288-0505-03
Dexmedetomidine	Dexmedetomidine hydrochloride 100 ug/mL	Injection, SolutionIntravenous	ProPharma Distribution	84549-505	84549-0505-03
Dexmedetomidine	Dexmedetomidine hydrochloride 100 ug/mL	Injection, SolutionIntravenous	Accord Healthcare Inc.	16729-239	16729-0239-93
Dexmedetomidine	Dexmedetomidine hydrochloride 100 ug/mL	Injection, Solution, ConcentrateIntravenous	WG Critical Care, LLC	44567-600	44567-0600-04
Dexmedetomidine	Dexmedetomidine hydrochloride 100 ug/mL	Injection, Solution, ConcentrateIntravenous	WG Critical Care, LLC	44567-601	44567-0601-04

All 13 Dexmedetomidine NDCs

Other NDCs under ANDA 202126

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202126
Product	Strength	Form · route	Labeler	Product NDC
Dexmedetomidine	Dexmedetomidine hydrochloride 200 ug/2mL	Injection, SolutionIntravenous	Piramal Critical Care Inc	66794-230
Dexmedetomidine	Dexmedetomidine hydrochloride 100 ug/mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-527
Dexmedetomidine	Dexmedetomidine hydrochloride 200 ug/2mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7323
Dexmedetomidine	Dexmedetomidine hydrochloride 200 ug/2mL	Injection, SolutionIntravenous	ProPharma Distribution	84549-230
Dexmedetomidine Hydrochloride	Dexmedetomidine hydrochloride 100 ug/mL	Injection, SolutionIntravenous	Sun Pharmaceuticals Industries, Inc.	57664-596
Dexmedetomidine Hydrochloride	Dexmedetomidine hydrochloride 100 ug/mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7122